Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts.

    Bacardi-Gascon M, Dueñas-Mena D, Jimenez-Cruz A.

    Diabetes Care. 2007 May;30(5):1264-5. Epub 2007 Feb 26. No abstract available. PMID: 17325260 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.

    Medina Santillán R, Reyes-García G, Mateos-García E.

    Proc West Pharmacol Soc. 2002;45:137-8. No abstract available. PMID: 12434558 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides]

    [No authors listed]

    MMW Fortschr Med. 2003 Aug 21;145(33-34):59. German. No abstract available. PMID: 14526583 [PubMed - indexed for MEDLINE]Related articles

    5.

    Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.

    Medina Santillán R, Reyes-García G, Mateos-García E.

    Proc West Pharmacol Soc. 2002;45:139-40. No abstract available. PMID: 12434559 [PubMed - indexed for MEDLINE]Related articles

    6.

    Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.

    Blonde L, Sandberg MI.

    Diabetes Technol Ther. 2000 Autumn;2(3):479-80. No abstract available. PMID: 11467351 [PubMed - indexed for MEDLINE]Related articles

    7.

    Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

    Bays HE, Goldberg RB, Truitt KE, Jones MR.

    Arch Intern Med. 2008 Oct 13;168(18):1975-83.PMID: 18852398 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.

    Chien HH, Chang CT, Chu NF, Hsieh SH, Huang YY, Lee IT, Lee WJ, Tang YJ, Sheu WH.

    J Chin Med Assoc. 2007 Nov;70(11):473-80.PMID: 18063500 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Unsurpassed glycaemic control made simple.

    [No authors listed]

    Cardiovasc J S Afr. 2003 Sep-Oct;14(5):288. No abstract available. PMID: 14664235 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

    Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE; Sitagliptin 036 Study Group.

    Diabetes Care. 2007 Aug;30(8):1979-87. Epub 2007 May 7. Erratum in: Diabetes Care. 2008 Aug;31(8):1713. PMID: 17485570 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).

    Viswanathan V, Chacko PT, Lavanya M, Tilak P.

    J Assoc Physicians India. 2006 Dec;54:965-6. No abstract available. PMID: 17334022 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

    Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

    Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects.

    Mudra M, Ercan-Fang N, Zhong L, Furne J, Levitt M.

    Diabetes Care. 2007 May;30(5):1272-4. Epub 2007 Feb 15. No abstract available. PMID: 17303787 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Hypoglycemic effect of Cecropia obtusifolia Bertol aqueous extracts on type 2 diabetic patients.

    Revilla-Monsalve MC, Andrade-Cetto A, Palomino-Garibay MA, Wiedenfeld H, Islas-Andrade S.

    J Ethnopharmacol. 2007 May 22;111(3):636-40. Epub 2007 Jan 18.PMID: 17291702 [PubMed - indexed for MEDLINE]Related articles

    16.

    The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.

    Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S; COM06 Study Investigators.

    Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. Epub 2007 Oct 24.PMID: 17919894 [PubMed - indexed for MEDLINE]Related articles

    17.

    [ADOPT study. Glitazone controls diabetes progression]

    Einecke D.

    MMW Fortschr Med. 2007 Jan;149(1-2):10, 12, 14. German. No abstract available. PMID: 17619358 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glyburide/metformin (Glucovance) for type 2 diabetes.

    [No authors listed]

    Med Lett Drugs Ther. 2000 Nov 13;42(1092):105-6. No abstract available. PMID: 11077467 [PubMed - indexed for MEDLINE]Related articles

    19.

    Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combination.

    Panikar V, Joshi SR, Bukkawar A, Nasikkar N, Santwana C.

    J Assoc Physicians India. 2007 May;55:333-7.PMID: 17844692 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.

    Zinman B, Hoogwerf BJ, Durán García S, Milton DR, Giaconia JM, Kim DD, Trautmann ME, Brodows RG.

    Ann Intern Med. 2007 Apr 3;146(7):477-85. Erratum in: Ann Intern Med. 2007 Jun 19;146(12):896. PMID: 17404349 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data